ARCHIVES

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

This article is from The Cancer Letter archive.

Vol. 26 No. 16 | April 21, 2000

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board

February 3, 1989

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997